The act of building trust with your pharmaceutical and biotech clients is similar to how trust is built between friends – both require time, mutual respect and appreciation. However, the components required to build trust between a CRO and its clients are complicated due to the involvement of various teams in this matrix relationship. I will discuss how numerous teams within the CRO and sponsor organization work together to establish trust, and ultimately a fruitful partnership.
Lynn Kamen and Michelle Miller Talk Bioanalysis: Past, Present, and Future
November 4, 2022
On this episode of Molecular Moments, Lynn Kamen, Ph.D., and Michelle Miller, Ph.D. DABT discuss their very different journeys to
Share This
